Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-λ1 -: Similarities with type I interferon signaling

被引:256
作者
Dumoutier, L
Tounsi, A
Michiels, T
Sommereyns, C
Kotenko, SV
Renauld, JC
机构
[1] Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium
[2] Univ Louvain, Expt Med Unit, B-1200 Brussels, Belgium
[3] Univ Louvain, Christian de Duce Inst Cellular Pathol, MIPA VIRO Unit, B-1200 Brussels, Belgium
[4] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
关键词
D O I
10.1074/jbc.M404789200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferon (IFN)-lambda1, -lambda2, and -lambda3 are the latest members of the class II cytokine family and were shown to have antiviral activity. Their receptor is composed of two chains, interleukin-28R/likely interleukin or cytokine or receptor 2 (IL-28R/LICR2) and IL-10Rbeta, and mediates the tyrosine phosphorylation of STAT1, STAT2, STAT3, and STAT5. Here, we show that activation of this receptor by IFN-lambda1 can also inhibit cell proliferation and induce STAT4 phosphorylation, further extending functional similarities with type I IFNs. We used IL-28R/LICR2-mutated receptors to identify the tyrosines required for STAT activation, as well as antiproliferative and antiviral activities. We found that IFN-lambda1-induced STAT2 tyrosine phosphorylation is mediated through tyrosines 343 and 517 of the receptor, which showed some similarities with tyrosines from type I IFN receptors involved in STAT2 activation. These two tyrosines were also responsible for antiviral and antiproliferative activities of IFN-lambda1. By contrast, STAT4 phosphorylation ( and to some extent STAT3 activation) was independent from IL-28R/LICR2 tyrosine residues. Taken together, these observations extend the functional similarities between IFN-lambdas and type I IFNs and shed some new light on the mechanisms of activation of STAT2 and STAT4 by these cytokines.
引用
收藏
页码:32269 / 32274
页数:6
相关论文
共 29 条
  • [1] Clifford JL, 2003, MOL CANCER THER, V2, P453
  • [2] Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
    Coccia, EM
    Severa, M
    Giacomini, E
    Monneron, D
    Remoli, ME
    Julkunen, I
    Cella, M
    Lande, R
    Uzé, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) : 796 - 805
  • [3] IFNs and STATs in innate immunity to microorganisms
    Decker, T
    Stockinger, S
    Karaghiosoff, M
    Müller, M
    Kovarik, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (10) : 1271 - 1277
  • [4] Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
  • [5] Demoulin JB, 2001, CELL GROWTH DIFFER, V12, P169
  • [6] CLONING AND SYNTHESIS OF INFECTIOUS CARDIOVIRUS RNAS CONTAINING SHORT, DISCRETE POLY(C) TRACTS
    DUKE, GM
    PALMENBERG, AC
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (04) : 1822 - 1826
  • [7] Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3
    Dumoutier, L
    Lejeune, D
    Hor, S
    Fickenscher, H
    Renauld, JC
    [J]. BIOCHEMICAL JOURNAL, 2003, 370 : 391 - 396
  • [8] Recruitment of Stat4 to the human interferon-α/β receptor requires activated Stat2
    Farrar, JD
    Smith, JD
    Murphy, TL
    Murphy, KM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) : 2693 - 2697
  • [9] The interleukin-10 family of cytokines
    Fickenscher, H
    Hör, S
    Küpers, H
    Knappe, A
    Wittmann, S
    Sticht, H
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (02) : 89 - 96
  • [10] IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex
    Kotenko, SV
    Gallagher, G
    Baurin, VV
    Lewis-Antes, A
    Shen, ML
    Shah, NK
    Langer, JA
    Sheikh, F
    Dickensheets, H
    Donnelly, RP
    [J]. NATURE IMMUNOLOGY, 2003, 4 (01) : 69 - 77